SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
ImmunityBio converts from Immunomedics
An SI Board Since February 2023
Posts SubjectMarks Bans Symbol
1341 49 0 IBRX
Emcee:  TinfoilHat Type:  Moderated
Introduction Market Data Compact
Investor in IBRX who previously benefited from crowd-sourced knowledge from the moderated Immunomedics forum
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1341The price also shows on yahoo finance and seems to be updating a lot so appears erippetoe-an hour ago
1340just for informational purposes, and things will change greatly before the morniluckydog881an hour ago
1339This probably only happens with tiered pricing. Retain the J-code for oncology. ghettogoulash-an hour ago
1338Furthermore, Anktiva would have no biosimilar competition to lower the price. Myghettogoulash-4 hours ago
1337Looks like IBRX closed at $7.77 (6.70 euros) in Europeerippetoe-4 hours ago
1336"Bioshield" sounds like something Elon Musk would come up with, so I nghettogoulash-5 hours ago
1335Can be some good info at reddit.com too but a lot of spam and noise over the laserippetoe-9 AM
1334That’s euros so still 7+. Exchange rate is 1.16 so 6.02 on that site is $7erippetoe19 AM
1333I was looking into that too but from what I can see the volume is tiny and the pluckydog8819 AM
1332Trading at $7+ in Europe. See ls-tc.de which is in euroserippetoe-8 AM
1331I find the Bioshield take on Anktiva a bit of a stretch given where it's at waitwatchwander-yesterday
1330Pancreatic cancer is an area PSS has been working on for decades. With that forwaitwatchwander-yesterday
1329I'm not sure that link is working. Ask AI, "Is ImmunityBio pursuing appghettogoulash1Saturday
1328I just realized something BIG. ImmunityBio is pursuing approval of Anktiva in chghettogoulash-Saturday
1327Sadly, they're going to get chemo anyway. Chemo is part of the "cocktaighettogoulash4Saturday
1326Thanks. I should have paid more attention to the filing. Here is an abbreviatejargonweary4Saturday
1325it would be based on the price on the day they actually sell shares - now they mluckydog881Saturday
1324I don’t see how at the market could be preset but who knowserippetoe-Saturday
1323We went into this week with just 15% institutional ownership. It will need to inOlecranon-Saturday
1322I am confused about whether the price for selling these shares, assuming the comjargonweary-Saturday
1321Huggenberg, in all of the excitement of the last few days, although I had intendFitzhughlaw4Saturday
1320This post by you (and catch you made from his post on X/Twitter) - ended up beinluckydog881Saturday
1319Let’s hopezagnut1-Saturday
1318They will definitely raise money. A few weeks ago there was a filing for issuinluckydog881Saturday
1317My big question now is after this news are they going to try to raise money and zagnut1-Saturday
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News